|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | ||||||||
| Short-term investments | ||||||||
| Short-term marketable securities | ||||||||
| Restricted cash | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Operating lease right-of-use asset | ||||||||
| Restricted cash | ||||||||
| Long-term marketable securities | ||||||||
| Other long-term assets | ||||||||
| Total assets | ||||||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Deferred rent, current portion | ||||||||
| Deferred revenue | ||||||||
| Accrued liabilities | ||||||||
| Operating lease liability, current portion | ||||||||
| Accrued research and development liabilities | ||||||||
| Accrued other liabilities | ||||||||
| Accrued compensation | ||||||||
| Total current liabilities | ||||||||
| Deferred revenue, less current portion | ||||||||
| Long-term deferred rent | ||||||||
| Convertible preferred stock warrant liability | ||||||||
| Total liabilities | ||||||||
| Long-term operating lease liability | ||||||||
| Convertible preferred stock, $0.0001 par value, 20,000,000 and 113,680,282 shares authorized at December 31, 2018 and 2017, respectively; 0 and 12,285,434 shares issued and outstanding at December 31, 2018 and 2017, respectively (aggregate liquidation preference of $0 and $129,445 at December 31, 2018 and 2017) | ||||||||
| Stockholders' equity | ||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized at June 30, 2020 and December 31, 2019; 33,161,289 and 32,950,836 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive income | ||||||||
| Accumulated deficit | ||||||||
| Total stockholders' equity | ||||||||
| Total liabilities and stockholders’ equity |
Loading...
